BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 2467458)

  • 1. T cell activation via cell-surface antigens other than the CD3/T cell receptor complex.
    Yokoyama WM; Shevach EM
    Year Immunol; 1989; 4():110-46. PubMed ID: 2467458
    [No Abstract]   [Full Text] [Related]  

  • 2. Alternative pathways for T lymphocyte activation.
    Shevach EM
    Prog Clin Biol Res; 1989; 288():127-40. PubMed ID: 2566174
    [No Abstract]   [Full Text] [Related]  

  • 3. T cell receptor/CD3 negative variants are unresponsive to stimulation through the Ly-6 encoded molecule, TAP.
    Bamezai A; Reiser H; Rock KL
    J Immunol; 1988 Sep; 141(5):1423-8. PubMed ID: 2842394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of accessory molecules in signal transduction of cytolytic T lymphocyte by anti-T cell receptor and anti-Ly-6.2C monoclonal antibodies.
    Leo O; Foo M; Henkart PA; Perez P; Shinohara N; Segal DM; Bluestone JA
    J Immunol; 1987 Dec; 139(11):3556-63. PubMed ID: 3316387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The majority of mouse spontaneous rosette-forming cells of thymic origin belong to the Ly-2+ subset.
    Lepault F; Fache MP; Gagnerault MC; Bach JF; Dardenne M
    Eur J Immunol; 1989 Apr; 19(4):605-9. PubMed ID: 2525098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of transformed T cell growth in vitro by monoclonal antibodies directed against distinct activating molecules.
    Merćep M; Bluestone JA; Noguchi PD; Ashwell JD
    J Immunol; 1988 Jan; 140(1):324-35. PubMed ID: 2891766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of T cells via the TAP molecule, a member in a family of activating proteins encoded in the Ly-6 locus.
    Yeh ET; Reiser H; Daley J; Rock KL
    J Immunol; 1987 Jan; 138(1):91-7. PubMed ID: 3023490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of T lymphocytes by cross-linking of glycophospholipid-anchored Thy-1 mobilizes separate pools of intracellular second messengers to those induced by the antigen-receptor/CD3 complex.
    Barboni E; Gormley AM; Pliego Rivero FB; Vidal M; Morris RJ
    Immunology; 1991 Apr; 72(4):457-63. PubMed ID: 1674734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte surface antigens. Introduction.
    Lanier L
    Fed Proc; 1985 Oct; 44(13):2863-4. PubMed ID: 2864288
    [No Abstract]   [Full Text] [Related]  

  • 10. CD44 contributes to T cell activation.
    Huet S; Groux H; Caillou B; Valentin H; Prieur AM; Bernard A
    J Immunol; 1989 Aug; 143(3):798-801. PubMed ID: 2568380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased surface expression of a newly identified 150-kDa dimer early after human T lymphocyte activation.
    Bougeret C; Mansur IG; Dastot H; Schmid M; Mahouy G; Bensussan A; Boumsell L
    J Immunol; 1992 Jan; 148(2):318-23. PubMed ID: 1530858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different modes of T-cell activation by monoclonal antibodies to the alpha/beta T-cell receptor and the CD3 complex.
    Schlitt HJ; Schwinzer R; Wonigeit K
    Transplant Proc; 1989 Feb; 21(1 Pt 1):147-8. PubMed ID: 2523121
    [No Abstract]   [Full Text] [Related]  

  • 13. Activation of T lymphocytes through the Ly-6 pathway is defective in A strain mice.
    Malek TR; Shevach EM; Danis KM
    J Immunol; 1989 Jul; 143(2):439-45. PubMed ID: 2525586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy.
    Verwilghen J; Vandenberghe P; Wallays G; de Boer M; Anthony N; Panayi GS; Ceuppens JL
    J Immunol; 1993 Feb; 150(3):835-46. PubMed ID: 7678624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human T cell activation: participation of Tll antigen (CD2, T,gp.50) in T cell-accessory cell interactions.
    Suthanthiran M
    Transplant Proc; 1987 Feb; 19(1 Pt 1):336-7. PubMed ID: 2908550
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence for a cyclosporine-resistant pathway of T cell activation triggered via the CD3/T cell receptor complex.
    Schlitt HJ; Schwinzer R; Kurrle R; Wonigeit K
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):103-9. PubMed ID: 2966472
    [No Abstract]   [Full Text] [Related]  

  • 17. Thy-1-negative and Ly-1-negative variants of T cells produce interleukin 2 in response to mitogens.
    Hollander N
    J Immunol; 1987 Jul; 139(2):437-42. PubMed ID: 2885371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of CD7 and CD3 molecules on the T cell surface.
    Sandrin MS; Vaughan HA; McKenzie IF
    Transplant Proc; 1989 Feb; 21(1 Pt 1):103-4. PubMed ID: 2468198
    [No Abstract]   [Full Text] [Related]  

  • 19. Functionally anergic lpr and gld B220+ T cell receptor (TCR)-alpha/beta+ double-negative T cells express CD28 and respond to costimulation with phorbol myristate acetate and antibodies to CD28 and the TCR.
    Giese T; Allison JP; Davidson WF
    J Immunol; 1993 Jul; 151(2):597-609. PubMed ID: 7687618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
    Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H
    Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.